THERASOLV 250 000 IU, powder for solution for injection/for infusion bottle, 8 ml
Active ingredients: UROKINASE (MAMMIFERE/HUMAIN/URINE)
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder for solution for injection or infusionbottle, 8 mlintraartérielle;intraveineuse;voie extracorporelle autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- THERASOLV 250 000 UI, poudre pour solution injectable/pour perfusion
- Pharmaceutical form
- poudre pour solution injectable ou pour perfusion
- Route of administration
- intraartérielle;intraveineuse;voie extracorporelle autre
- Presentation description
- 1 flacon(s) en verre de 8 ml
- Marketing authorisation holder
- THERADIAL
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Jun 2021
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67477197CIP75506752CIP133400955067528Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| UROKINASE (MAMMIFERE/HUMAIN/URINE)poudre | 250 000 UI · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.